Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells
2011

Intracellular Antibodies Against HPV E7 Reduce Cancer Cell Growth

publication Evidence: moderate

Author Information

Author(s): Accardi Luisa, Donà Maria Gabriella, Mileo Anna M, Paggi Marco G, Federico Antonio, Torreri Paola, Petrucci Tamara C, Accardi Rosita, Pim David, Tommasino Massimo, Banks Lawrence, Chirullo Barbara, Giorgi Colomba

Primary Institution: Istituto Superiore di Sanità, Rome, Italy

Hypothesis

Can intracellular antibodies targeting the E7 oncoprotein of HPV 16 inhibit the proliferation of HPV-positive cancer cells?

Conclusion

The study found that specific intracellular antibodies can inhibit the growth of HPV-positive cancer cells by targeting the E7 oncoprotein.

Supporting Evidence

  • The antibodies were shown to inhibit the proliferation of HPV-positive SiHa cells.
  • The study demonstrated that the antibodies bind to the E7 oncoprotein without interfering with pRb.
  • Cell viability assays confirmed the specificity of the antibodies in targeting HPV-positive cells.

Takeaway

Scientists created special antibodies that can stop cancer cells from growing by targeting a part of the virus that causes the cancer.

Methodology

The study used retroviral transduction to express single-chain antibodies in HPV16-positive SiHa cells and assessed their effects on cell proliferation through colony formation and viability assays.

Limitations

The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1471-2407-11-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication